---
title: "JAFRON released its 2024 annual performance, with a net profit attributable to shareholders of 820 million yuan, a year-on-year increase of 87.91%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236061336.md"
description: "JAFRON released its 2024 annual report, with operating revenue of 2.677 billion yuan, a year-on-year increase of 39.27%; net profit attributable to shareholders of the parent company was 820 million yuan, a year-on-year increase of 87.91%; net profit excluding non-recurring gains and losses was 779 million yuan, a year-on-year increase of 90.46%. Basic earnings per share were 1.05 yuan, and it plans to distribute a cash dividend of 8.00 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-15T12:52:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236061336.md)
  - [en](https://longbridge.com/en/news/236061336.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236061336.md)
generator: "portal-rs"
---

# JAFRON released its 2024 annual performance, with a net profit attributable to shareholders of 820 million yuan, a year-on-year increase of 87.91%

According to the Zhitong Finance APP, JAFRON (300529.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 2.677 billion yuan, a year-on-year increase of 39.27%. The net profit attributable to shareholders of the listed company was 820 million yuan, a year-on-year increase of 87.91%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 779 million yuan, a year-on-year increase of 90.46%. The basic earnings per share were 1.05 yuan. It is proposed to distribute a cash dividend of 8.00 yuan (tax included) for every 10 shares to all shareholders

### Related Stocks

- [300529.CN](https://longbridge.com/en/quote/300529.CN.md)

## Related News & Research

- [Cofoe Medical FY26 H1 profit climbs 21.9% to RMB 203.2 million; revenue rises 38.5% to RMB 2.07 billion](https://longbridge.com/en/news/297291709.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)
- [Mark Cuban Says 'We Will Always Pay More' as PBMs Set Drug Prices, Calls Healthcare Conglomerates 'Too Big to Care'](https://longbridge.com/en/news/297034426.md)
- [08:02 ETMonod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays](https://longbridge.com/en/news/297041656.md)
- [Adaptyv Bio raises $40 million Series A as ACE Ventures joins round](https://longbridge.com/en/news/297004059.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**